Related Experiment Videos
Clotting abnormalities in chronic liver disease.
F Violi1, D Ferro, C Quintarelli
1Università degli Studi di Roma La Sapienza, Istituto di I Clinica Medica Generale, Italia.
Digestive Diseases (Basel, Switzerland)
|January 1, 1992
Summary
Chronic liver disease (CLD) frequently causes clotting factor reduction and low platelet counts. Assessing these clotting changes can help evaluate liver function and predict patient prognosis.
Area of Science:
- Hepatology
- Hematology
- Clinical Biochemistry
Background:
- Chronic liver disease (CLD) significantly impacts hemostasis.
- Coagulation abnormalities are common in CLD patients.
- These changes affect liver function and disease prognosis.
Purpose of the Study:
- To summarize the key hemostatic alterations in chronic liver disease.
- To highlight the clinical significance of coagulation assessment in CLD.
Main Methods:
- Review of common clotting abnormalities in CLD.
- Discussion of vitamin-K-dependent and independent factor synthesis.
- Analysis of platelet count and hyperfibrinolysis in CLD.
Main Results:
- Reduced synthesis of clotting factors is a frequent finding in CLD.
- Low platelet count may not always correlate with prolonged bleeding.
- Hyperfibrinolytic syndrome often occurs in decompensated CLD, increasing bleeding risk.
Conclusions:
- Coagulation system assessment is valuable for evaluating liver function in CLD.
- Hemostatic changes can serve as prognostic indicators for patients with CLD.